Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Targets to Therapies: Mitochondrial Target Validation

    Targets to Therapies: Mitochondrial Target Validation supports researchers studying mitochondrial targets to build evidence that guides therapeutic decisions for Parkinson’s disease.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Functional Target Validation for Alzheimer's Disease-Related Dementias

    This grant supports research to rigorously validate new therapeutic targets for Alzheimer's Disease-Related Dementias, aiming to accelerate treatment development through phased, milestone-driven projects.

    HHS-NIH11Forecasted Nov 6, 2026· 10d$1,800,000Forecasted

    Impact Awards

    The Parkinson's Foundation Impact Awards fund bold research to advance understanding of Parkinson’s disease biology or accelerate new interventions.

    PFDue Mar 3, 2027$200,000

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases supports researchers developing human-centered models and assays to discover and optimize small-molecule treatments.

    EMD Group (Merck KGaA)Forecasted Aug 31, 2027$500,000Forecasted

    Principal Investigator Award – UMDF 2026 Research Grant Program

    Principal Investigator Award – UMDF 2026 Research Grant Program supports independent investigators' research to improve diagnosis, develop treatments, and pursue cures for primary mitochondrial disease.

    UMDFForecasted Mar 2, 2027$100,000Forecasted

    Accelerating Drug Discovery for Frontotemporal Degeneration

    Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.

    Alzheimers Drug DiscoveryForecasted Mar 15, 2027$300,000Forecasted